Apyx Medical Corporation
General ticker "APYX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $70.6M (TTM average)
Apyx Medical Corporation follows the US Stock Market performance with the rate: 56.1%.
Estimated limits based on current volatility of 2.5%: low 3.13$, high 3.30$
Factors to consider:
- Earnings expected soon, date: 2026-03-12 bmo
- Total employees count: 220 (-12.7%) as of 2024
- US accounted for 70.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Product liability, Trade secret risks, Geopolitical risks, Cybersecurity threats
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.05$, 3.06$]
- 2025-12-31 to 2026-12-31 estimated range: [1.10$, 3.12$]
Financial Metrics affecting the APYX estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -31.40 <= 0.01
- Positive: 19.40 < Shareholder equity ratio, % of 21.91 <= 42.68
- Positive: Industry inventory ratio change (median), % of -1.37 <= -0.16
- Positive: Inventory ratio change, % of -2.35 <= -0.75
- Positive: -4.43 < Investing cash flow per share per price, % of -1.26
Short-term APYX quotes
Long-term APYX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $44.51MM | $52.35MM | $48.10MM |
| Operating Expenses | $68.07MM | $69.61MM | $66.95MM |
| Operating Income | $-23.56MM | $-17.26MM | $-18.84MM |
| Non-Operating Income | $0.65MM | $-4.02MM | $-4.46MM |
| Interest Expense | $0.01MM | $2.48MM | $5.91MM |
| R&D Expense | $4.54MM | $4.84MM | $5.08MM |
| Income(Loss) | $-22.91MM | $-21.28MM | $-23.31MM |
| Taxes | $0.37MM | $-2.43MM | $0.25MM |
| Profit(Loss)* | $-23.18MM | $-18.71MM | $-23.46MM |
| Stockholders Equity | $37.58MM | $26.70MM | $14.21MM |
| Inventory | $11.80MM | $9.92MM | $7.56MM |
| Assets | $51.77MM | $79.24MM | $64.84MM |
| Operating Cash Flow | $-20.28MM | $-5.25MM | $-18.05MM |
| Capital expenditure | $1.01MM | $0.53MM | $0.72MM |
| Investing Cash Flow | $-1.01MM | $6.73MM | $-0.72MM |
| Financing Cash Flow | $0.22MM | $32.17MM | $6.75MM |
| Earnings Per Share** | $-0.67 | $-0.54 | $-0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.